We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients With HIV/HCV Coinfection: Results of an Italian Compassionate Use Program.
- Authors
Andreoni, Massimo; Teti, Elisabetta; Antinori, Andrea; Milazzoi, Laura; Sollima, Savatore; Rizzardini, Giuliano; Di Biagio, Antonio; Saracino, Annalisa; Bruno, Raffaele; Borghi, Vanni; De Luca, Andrea; Cattelan, Annamaria; Hasson, Hamid; Taliani, Gloria; Monforte, Antonella D'Arminio; Mastroianni, Claudio Maria; Di Perri, Giovanni; Bigoni, Sara; Puoti, Massimo; Spinetti, Angiola
- Abstract
Patients coinfected with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) are at high risk of liver disease progression. We report a favorable safety profile and SVR12 rates of 96.7% among HIV/HCV coinfected patients participating in an Italian compassionate-use program of ombitasvir/ paritaprevir/ritonavir + dasabuvir (OBV/PTV/r + DSV) ± ribavirin (RBV).
- Subjects
HEPATITIS C virus; HEPATITIS C transmission; HIV prevention; DRUG efficacy; RIBAVIRIN; PATIENTS
- Publication
Clinical Infectious Diseases, 2017, Vol 64, Issue 5, p680
- ISSN
1058-4838
- Publication type
Article
- DOI
10.1093/cid/ciw846